Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine

Patients with metastatic melanoma were immunized with an immunodominant peptide derived from the gp100 melanoma-melanocyte differentiation Ag that was modified to increase binding to HLA-A(+)0201. A total of 10 of 11 patients who received the g209–2M peptide alone developed precursors reactive with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rosenberg, Steven A., Yang, James C., Schwartzentruber, Douglas J., Hwu, Patrick, Marincola, Francesco M., Topalian, Suzanne L., Restifo, Nicholas P., Sznol, Mario, Schwarz, Susan L., Spiess, Paul J., Wunderlich, John R., Seipp, Claudia A., Einhorn, Jan H., Rogers-Freezer, Linda, White, Donald E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1999
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2249693/
https://ncbi.nlm.nih.gov/pubmed/10415076
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak